Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,144.14
(
-1.16%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 90128

Monday, 02/08/2010 4:24:31 AM

Monday, February 08, 2010 4:24:31 AM

Post# of 257579
Botox/Dysport info from AGN’s 4Q09 CC:

1. Dysport’s 4Q09 US market share: low double-digit % in cosmetic indications, and a negligible % in therapeutic indications (due to delays in Ipsen’s obtaining reimbursement).

2. Worldwide 4Q09 Botox sales were +0.7% year-over-year in local currencies (+5.6% in dollars).

3. Botox’s worldwide market share in all indications in 3Q09 (the most recent quarter for which data are available) is 83%.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today